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SHORT REPORT
Abnormal expression of the KLF8 (ZNF741) gene in a
female patient with an X;autosome translocation
t(X;21)(p11.2;q22.3) and non-syndromic mental
retardation
A-M Lossi, F Laugier-Anfossi, D Depetris, J Gecz, A Gedeon, F Kooy, C Schwartz,
M-G Mattei, M-F Croquette, L Villard
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Non-syndromic X linked mental retardation (MRX) is a
heterogeneous group of conditions in which all patients
have mental retardation as the only constant phenotypic
feature. We have identified a female patient with mental
retardation and a balanced translocation involving
chromosomes X and 21, t(X;21)(p11.2;q22.3). Physical
mapping of the translocation breakpoint on the human X
chromosome was performed using fluorescence in situ
hybridisation. We have mapped the X chromosome break-
point to a 21 kb DNA fragment upstream of the first exon
of the KLF8 (ZNF741) gene in Xp11.21. We have subse-
quently shown that the KLF8 transcript is no longer
detected in cells from the patient, although KLF8
expression is otherwise normally present in control
lymphoblasts. Mutation screening of probands from 20
unrelated XLMR families linked to the proximal short arm of
the human X chromosome failed to show any mutation in
the coding region of the KLF8 gene.
Non-syndromic X linked mental retardation (MRX) is avery heterogeneous group of conditions in which allpatients have mental retardation as the only distin-
guishing phenotypic feature. During the past few years,
several MRX genes have been identified: FMR2,1 2 GDI1,3
OPHN1,4 PAK3,5 RPS6KA3,6 IL1RAPL,7 TM4SF2,8 and ARHGEF6.9
Despite the large number of familial cases of non-syndromic
mental retardation available for study, systematic mutation
screening in these genes has failed to find a major locus for
this group of conditions. Only a few mutations have been
described in each of the MRX genes (six mutations identified
among the 76 MRX families currently recognised by the
HUGO gene nomenclature committee, http://
www.gene.ucl.ac.uk/nomenclature/). The number of genes
that could be responsible for a MRX phenotype based on over-
lapping linkage intervals has previously been discussed.10
However, the currently available molecular data seem to show
that no major locus exists; rather, probably, a large number of
X linked genes can cause a non-syndromic mental retardation
phenotype when mutated.
Three MRX genes (OPHN1, TM4SF2, ARHGEF6) were identi-
fied on the basis of their interruption by X;autosome translo-
cations in female patients with mental retardation. The
normal X chromosome is usually inactivated in the cells of
females with such a balanced chromosomal rearrangement to
maintain a correct dosage in the autosomal regions translo-
cated to the X chromosome.11 Hence, any gene interrupted by
the X chromosome breakpoint is potentially responsible for
the phenotype observed in the patient.
We have identified a female patient with mental retardation
and a de novo balanced translocation involving chromosomes
X and 21. Karyotype analysis showed a t(X;21)(p11.2;q22.3).
We focused our attention on the X chromosome in order to
determine if a gene was interrupted in the patient’s DNA. This
choice was dictated by the fact that a significant number of X
linked mental retardation (XLMR) families are genetically
linked to the proximal short arm of the human X chromosome
and that any X linked gene that was interrupted in the patient
would be a good XLMR candidate gene.
We have mapped the X chromosome breakpoint region to a
21 kb restriction fragment which is located immediately
upstream of the first exon of the KLF8 gene.KLF812 is a CACCC
box binding protein that associates with the transcriptional
corepressor C-terminal binding protein (CtBP)13 and represses
transcription. It contains three kruppel-like zinc finger motifs
at its C-terminus. The KLF8 gene is expressed ubiquitously.
We determined that the KLF8 transcript is absent from
lymphoblasts of the translocation patient although it is easily
detected in normal controls. This fact prompted us to search
for KLF8 mutations in 20 XLMR families linked to this region
of the human X chromosome. Unfortunately, no disease caus-
ing mutation was identified in this panel of families.
Therefore, it is unlikely that KLF8 is responsible for a large
proportion of X linked mental retardation.
MATERIAL AND METHODS
Case report
The patient is the fourth child of healthy, unrelated parents.
She was referred at the age of 5 years because her psychomo-
tor development was delayed. Birth weight was 3400 g, length
was 48 cm, and OFC was 35 cm. Apgar scores were 10 at one
and five minutes. At the age of 9 months, she presented with
seizures which never recurred. She walked at the age of 2 years
and began speaking in short sentences at 4 years. Aged 5
years, she cannot run nor stand on one leg. She cannot stand
up alone from a sitting position. Examination at this age
showed genu valgum, pelvic muscle atrophy, and global hypo-
tonia. Her development was evaluated to be 2.5 years for
motor skills and adaptation and 4 years for language and
sociability. At 5 years, her weight was at +4 SD and her height
at +1.5 SD. Blood examination, routine biochemical analysis,
nerve conduction velocity, and MRI were normal. Karyotype
analysis showed a de novo balanced translocation
t(X;21)(p11.2;q22.3).
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XLMR families
Ten probands came from the Greenwood-Miami collection of
XLMR families. These consisted of one male each with
MRX7,14 15 MRX8,16 17 Miles-Carpenter syndrome,18 19 and Stocco
dos Santos syndrome,20 21 and families K8360, K8820, K8825,
K8835, K8900, and K8923 (C Schwartz, unpublished data).
K8360 is a MRX family localised between MAOA and DXS990,
K8820 aMRX family localised between DXS8015 and DXS995,
K8825 a small XLMR family in which males have relative
macrocephaly and prominent ears, and a broad localisation
between DXS999 and DXS424, K8835 is a MRX family with
localisation between RBM3 and DXS990, K8900 is a XLMR
family in which the affected males have growth impairment,
marked developmental delay (no speech or ambulation),
seizures, athetosis, and spasticity, and a broad localisation
between DXS993 and DXS1002, and K8923, previously
reported22 as having features of Renpenning syndrome,23 24 has
been localised between DXS8035 and DXS424. The eleventh
case is a patient from the MRX9 family localised between
DXS164 and DXS453.25 Nine additional families came from
Australia. These include five previously published MRX fami-
lies, MRX1, MRX12, MRX13, MRX17, and MRX31,10 one
unpublished family (A Gedeon, unpublished data), and three
families with syndromic features26 (A Gedeon, unpublished
data). X chromosome map localisation for all these families
overlaps that of the position of the KLF8 gene.
X chromosome inactivation analysis
Replication studies of the X chromosomes of cells from the
patient were performed using a very late terminal BrdU pulse
for the last three hours of culture. Chromosomal DNA was
denatured in 70% formamide for two minutes at 70°C, then
covered with a fluorescein conjugated anti-BrdU antibody to a
final concentration of 25 µg/ml in PBS, and incubated for 60
minutes at room temperature. The slides were then washed 3
× 5 minutes in PBS, and the chromosomes were counter-
stained with DAPI. Hybridisation with an X alphoid probe was
performed simultaneously. Molecular analysis of X chromo-
some inactivation at the AR locus was performed as described
elsewhere.27
Fluorescence in situ hybridisation (FISH)
The probes (DNA from YACs, PACs, and restriction fragments)
were labelled by random priming with bio-16-dUTP and in
situ hybridised at a final concentration of 20 ng/µl. The
hybridisation signals were made visible with fluorescein
labelled avidin following standard protocols.28 Chromosomes
were counterstained with propidium iodine diluted in pH 11
antifade.
In silico analysis
The Nix genomic sequence analysis program at the UK
Human Genome Mapping Project (http://
www.hgmp.mrc.ac.uk/NIX/) was used for in silico analysis.
Sequence comparisons were performed using the Blast
algorithm at NCBI (http://www.ncbi.nlm.nih.gov/blast/).
RNA preparation and RT-PCR experiments
PolyA+ RNA was prepared using lymphocytes and the Quick-
Prep mRNA purification kit according to the instructions of
the manufacturer (Pharmacia). Reverse transcription of 500
ng of mRNAwas performed in 50 µl of 1 × Superscript reaction
buffer (Gibco BRL) containing 3 ng/µl of dN6, 40 units of Rna-
sin (Promega), 1 mmol/l dNTP, and 200 units of Superscript II
reverse transcriptase (Gibco BRL). RT-PCR was performed
using 1/10th of the first strand reaction.
Mutation screening in XLMR probands
The KLF8 gene was sequenced for each patient using genomic
DNA as a template. Primers were designed to amplify each
exon of the gene (table 1). The PCR samples were directly
sequenced, without subcloning, after purification with a Qia-
gen PCR purification kit, using a LiCor DNA sequencer and
M13 tailed primers.
RESULTS
X chromosome inactivation analysis
Metaphase spreads of lymphocytes of the patient with the
X;21 translocation were studied for X chromosome inactiva-
tion. Forty cells were examined on three different slides (120
cells in total) and in all cases the normal X chromosome was
found to be inactivated. This result was confirmed with a PCR
assay using the polymorphic repeat sequence present in the
androgen receptor gene, which showed a totally skewed X
chromosome inactivation pattern (data not shown).
Mapping of the X chromosome Xp11.21 breakpoint
using FISH
In order to map the translocation breakpoint on the X
chromosome, we initially used the karyotype information and
Table 1 Oligonucleotides used to amplify the six exons of KLF8 using genomic DNA as a template
Exon Forward (5′-3′) Reverse (5′-3′) Exon size Intron size
1 GCCGGAACTGAATTGGTAGG AGGGGGATAGAATCTAGACG 436 bp 17.8 kb
2 GAACACACATAACATTAATGGC AAATTCTGTAATCACTACCAGG 74 bp 15.9 kb
3 TGCTTGCATGTCTCTTCAGG GATAGGATGACTCTAAAAGGG 565 bp 4.8 kb
4 TTAAGGTGGGACAAACTGGG GTTCCACCTATACATATGTGC 112 bp 0.7 kb
5 GCCGATATGATGTGGCACC TCCATGAATGGAGCCTGTGC 140 bp 10 kb
6 CTTCTAGTATCCGATCATCC GCAAGCTGAAGTCAAAGAGG 872 bp –
Figure 1 Fluorescence in situ hybridisation of metaphase
chromosomes from the translocation patient using PAC dJ148M19
as a probe. The PAC clone hybridises with the normal X
chromosome and the two translocated chromosomes, a result
expected for a clone spanning the translocation breakpoint.
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a set of four overlapping YAC clones selected in a contig span-
ning the Xp11.21 genomic region.29 We initially selected four
YAC clones for further analysis: 857_g_12, 662_c_2, 945_e_12
and 973_d_2. These YACs were used to perform FISH experi-
ments on chromosomes of the translocation patient. Two of
them (YACs 945_e_12 and 857_g_12) were found to cross the
translocation breakpoint (data not shown). To narrow the
breakpoint region further, we next used in the same type of
experiment PAC clones originating from a bacterial clone con-
tig constructed by the Sanger Center in the same region
(http://www.sanger.ac.uk/HGP/ChrX). PAC dJ148M19 was
found to cross the translocation breakpoint (fig 1). This PAC
clone, positive for marker DXS741, has a size of 177 kb and its
sequence is available (Genbank accession number AL050309).
We digested the dJ148M19 clone with the KpnI, HindIII, and
EcoRI restriction endonucleases and the different restriction
fragments were excised from agarose gels and used once again
in FISH experiments. A 21 kb KpnI restriction fragment was
found to cross the translocation breakpoint (fig 2).
The KLF8 transcript is absent from the translocation
patient cells
In silico analysis of the PAC dJ148M19 sequence was
performed using the Nix genomic sequence analysis tool (see
Methods). This analysis showed that the PAC contained exons
1 to 5 of the KLF8 gene (fig 2). No other obvious transcription
unit was detected using various gene feature prediction
programs or by comparison with the transcribed sequences
databases (data not shown). The 21 kb KpnI restriction
fragment derived from PAC dJ148M19, which crosses the
breakpoint, is located immediately upstream of the first exon
of the KLF8 gene. We thus wanted to determined if KLF8 was
properly expressed in cells from the patient. For this purpose,
we performed multiplex RT-PCR experiments using primers
specific for the KLF8 cDNA together with primers from a
ubiquitously expressed gene located outside the breakpoint
region (the XNP/ATR-X gene in Xq13.3). Our results show that
the KLF8 transcript is almost totally absent in the patient’s
lymphocytes although it is easily detected in a control sample
(fig 3).
KLF8 is composed of six exons and exon 2 is
alternatively spliced
In order to explain why the KLF8 transcript could not be
detected in cells from the translocation patient, we tested for
the potential presence of unknown additional 5′ exons. For
this purpose, we first checked that the published sequence of
KLF8 was correct. RT-PCR amplification of the KLF8 transcript
together with database (ESTs and genomic sequence)
comparisons showed that nucleotides 1-254 of the KLF8 cDNA
Figure 2 Schematic representation of the translocation breakpoint region in Xp11.21. (Above) Physical map of the Xp11.21 region29 (not to
scale) with the YAC clones which were used for FISH experiments in our study. PAC clone dJ148M19 is also shown. (Below) Structure of the
dJ148M19 PAC clone showing the five KLF8 exons with their sizes and the sizes of the introns (not to scale), the localisation of the 21 kb KpnI
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Figure 3 KLF8 expression analysis using RT-PCR. Two cDNA
fragments were simultaneously amplified using the father, mother, or
patient lymphocyte mRNA as a starting material. PC: positive control
(mRNA from an unrelated normal subject). NC: negative control (no
mRNA added to the reaction). In each case, the genomic DNA
cannot be amplified using these PCR conditions and the size of the
amplified fragments correspond to the KFL8 (180 bp) and
XNP/ATR-X (450 bp) cDNAs. Although the translocation patient
sample was overloaded, this experiment shows that the KLF8
transcript is almost totally absent in the patient’s lymphocytes (a very
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(GenBank entry NM_007250) do not belong to the KLF8 tran-
script but rather correspond to a sequence on chromosome 2
(data not shown). The KLF8 cDNA reported in GenBank is
thus a coligated clone. Analysis of the KFL8 ESTs (Unigene
cluster Hs.320861) showed no evidence for any additional 5′
sequence. We performed RT-PCR experiments in the 5′ region
of the KLF8 transcript using human fetal and adult brain
cDNA libraries, a KLF8 specific primer, and primers corre-
sponding to the cDNA library cloning vector. We were unable
to extend the 5′ sequence but these experiments showed that
exon 2 of KLF8 is alternatively spliced (data not shown). In
addition, sequence comparison between the KLF8 cDNA
sequence, PAC clone dJ148M19, and an overlapping BAC clone
(bB188A5) allowed us to show that KLF8 is composed of six
exons spanning 50 kb of genomic DNA in Xp11.21.
Mutation screening in MRX families
The fact that the KLF8 gene was not found to be expressed in
cells from the translocation patient using RT-PCR made it a
good candidate for XLMR. In order to test this hypothesis, we
screened a cohort of 20 unrelated XLMR families linked to the
same interval of the human X chromosome for mutations in
the gene (see Methods). Direct sequencing of each exon of the
KLF8 gene (table 1) using genomic DNA as a template was
performed. This analysis failed to show any disease causing
mutations.
DISCUSSION
We have precisely mapped the X chromosome breakpoint of a
female patient with an X;autosome translocation
t(X;21)(p11.2;q22.3) and mental retardation. The breakpoint
is contained within a 21 kb KpnI restriction fragment
originating from PAC clone dJ148M19 whose complete
sequence was available. Two observations lead us to think that
we may have found the molecular basis of the mental retarda-
tion of the patient: (1) numerous XLMR families are linked to
this region of the human X chromosome and (2) PAC
dJ148M19 contains the KLF8 gene as its single transcription
unit. Additionally, RT-PCR experiments determined that no
transcripts of the KLF8 gene are present in lymphocytes from
the patient although this transcript is easily detected in
control lymphocytes. These results prompted us to look for
KLF8 mutations in the DNA of 20 unrelated XLMR probands
originating from families linked to the proximal short arm of
the human X chromosome. However, we did not find disease
causing mutations in these subjects after sequencing each
exon of the KLF8 gene.
There are some important implications from these results. If
the KLF8 gene is indeed responsible for the mental retardation
observed in our patient, the lack of gene mutations in the 20
unrelated XLMR patients would mean that mutations in KLF8
are not a frequent cause of XLMR. However, it should be
pointed out that the other genes for which a causative effect
on mental retardation has been proven are found mutated in
only approximately 2% of the screened FRAXA negative males
with MR. It is thus possible that we have not screened enough
cases to identify a potentially disease causing mutation in
another family. Many more cases should be screened in order
to rule out this alternative hypothesis. In addition,we have not
performed expression studies on the KLF8 mRNA in the 20
families studied, since RNA samples were not available, and
we thus cannot rule out the possibility that transcription is
altered in one or several of these families.
On the other hand, since we are dealing with an
X;autosome translocation, it is still possible that the patient’s
mental retardation is the result of a molecular defect (for
example, an interrupted gene) on chromosome 21. If the
involvement of the X chromosome is ruled out, this alternative
hypothesis needs to be considered since the 21q22.3 region
has been shown to be associated with some of the features of
Down syndrome, especially mental retardation.30 To examine
this possibility further, a detailed physical mapping of the
chromosome 21 breakpoint will need to be carried out. Even if
a gene is not found to be broken by the breakpoint on
chromosome 21, there is the possibility that a nearby gene was
put under the control of a different promoter. Since the break-
point on the X chromosome maps in the promoter region of
the KLF8 gene, and since this gene is not expressed any more
in the patient’s cells, it may be that a gene on chromosome 21
has been placed under the control of the KLF8 promoter or
that the KLF8 gene is now expressed under the control of a
promoter associated with a gene on chromosome 21. Further
studies will be needed to determine which hypothesis is true.
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